The biology of TNF blockade

This publication has 37 references indexed in Scilit:

• Investigation of promoter polymorphisms in the tumor necrosis factor-?? and interleukin-10 genes in liver transplant patients
  Transplantation, 2002
• Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
  Published by Elsevier ,2002
• The Proximal Promoter Region Is Essential for Lipopolysaccharide Induction and Cyclic AMP Inhibition of Mouse Tumor Necrosis Factor-α
  Journal of Interferon & Cytokine Research, 2002
• Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation
  Bone Marrow Transplantation, 2002
• Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism
  Scandinavian Journal of Gastroenterology, 2002
• The combination of tumor necrosis factor ? blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model
  Arthritis & Rheumatism, 2001
• Pharmacogenetic association between the TNF receptor 2 genotype and response to infliximab treatment in Crohn disease
  Gastroenterology, 2001
• Arguments for interleukin 1 as a target in chronic arthritis
  Annals of the Rheumatic Diseases, 2000
• Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies
  Genes & Immunity, 2000
• Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
  New England Journal of Medicine, 1999